164 related articles for article (PubMed ID: 29691252)
1. High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis.
Avanzato D; Pupo E; Ducano N; Isella C; Bertalot G; Luise C; Pece S; Bruna A; Rueda OM; Caldas C; Di Fiore PP; Sapino A; Lanzetti L
Cancer Res; 2018 Jul; 78(13):3432-3444. PubMed ID: 29691252
[TBL] [Abstract][Full Text] [Related]
2. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
3. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
4. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
[TBL] [Abstract][Full Text] [Related]
5. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
[TBL] [Abstract][Full Text] [Related]
6. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
Lee JH; Liu R; Li J; Wang Y; Tan L; Li XJ; Qian X; Zhang C; Xia Y; Xu D; Guo W; Ding Z; Du L; Zheng Y; Chen Q; Lorenzi PL; Mills GB; Jiang T; Lu Z
Mol Cell; 2018 Apr; 70(2):197-210.e7. PubMed ID: 29677490
[TBL] [Abstract][Full Text] [Related]
7. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
Lin C; Xu X
Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner.
Mamo M; Ye IC; DiGiacomo JW; Park JY; Downs B; Gilkes DM
Cancer Res; 2020 Nov; 80(22):4998-5010. PubMed ID: 33023947
[TBL] [Abstract][Full Text] [Related]
9. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.
Schmidt M; Voelker HU; Kapp M; Krockenberger M; Dietl J; Kammerer U
J Cancer Res Clin Oncol; 2010 Feb; 136(2):219-25. PubMed ID: 19655166
[TBL] [Abstract][Full Text] [Related]
10. t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells.
Lenz G; Hamilton A; Geng S; Hong T; Kalkum M; Momand J; Kane SE; Huss JM
Clin Cancer Res; 2018 Mar; 24(5):1216-1226. PubMed ID: 29180608
[No Abstract] [Full Text] [Related]
11. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
[TBL] [Abstract][Full Text] [Related]
12. Akt substrate TBC1D1 regulates GLUT1 expression through the mTOR pathway in 3T3-L1 adipocytes.
Zhou QL; Jiang ZY; Holik J; Chawla A; Hagan GN; Leszyk J; Czech MP
Biochem J; 2008 May; 411(3):647-55. PubMed ID: 18215134
[TBL] [Abstract][Full Text] [Related]
13. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP.
Jiang S; Wang X; Song D; Liu X; Gu Y; Xu Z; Wang X; Zhang X; Ye Q; Tong Z; Yan B; Yu J; Chen Y; Sun M; Wang Y; Gao S
Cancer Res; 2019 Jun; 79(12):3063-3075. PubMed ID: 30987997
[TBL] [Abstract][Full Text] [Related]
15. WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.
Henriques AFA; Matos P; Carvalho AS; Azkargorta M; Elortza F; Matthiesen R; Jordan P
Arch Biochem Biophys; 2020 Jan; 679():108223. PubMed ID: 31816312
[TBL] [Abstract][Full Text] [Related]
16. EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
Jung KH; Lee EJ; Park JW; Lee JH; Moon SH; Cho YS; Lee KH
PLoS One; 2019; 14(9):e0221294. PubMed ID: 31532771
[TBL] [Abstract][Full Text] [Related]
17. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
[TBL] [Abstract][Full Text] [Related]
18. Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.
Wang J; Ji H; Niu X; Yin L; Wang Y; Gu Y; Li D; Zhang H; Lu M; Zhang F; Zhang Q
Dis Markers; 2020; 2020():6103542. PubMed ID: 32377271
[TBL] [Abstract][Full Text] [Related]
19. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
20. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer.
Li C; Chen Q; Zhou Y; Niu Y; Wang X; Li X; Zheng H; Wei T; Zhao L; Gao H
FASEB J; 2020 Oct; 34(10):13333-13344. PubMed ID: 32816365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
